Screening is Open! Healthy Adults needed

Study Details

This is a research study for an investigational drug being developed as a supplement to a reduced calorie diet and increased physical activity for long-term weight management. Tirzepatide is an injectable prescription drug that has been approved by the FDA for chronic weight management, in addition to diet, exercise, and oral (by mouth) medications. The use of tirzepatide in combination with the study drug in this study is investigational.

Fortrea Dallas, TX is recruiting for:

-Healthy Males and Females, age 18-64

-Body Mass Index between 22-30

-Study involves 1 stay of 6 nights & 9 follow-up visits*

-Compensation up to $13,324 may be provided for time and participation

-Refer a friend to receive $350 per qualified referral

*Additional inpatient or outpatient visit may be required.

Additional Details

2a:

Check-in: Jun 8

Check-out: Jun 14

OPV: Jun 16, 19, 23, 30, Jul 7, 21, Aug 4, 18, Sep 1

OR

2b:

Check-in: Jun 16

Check-out: Jun 22

OPV: Jun 24, 27, Jul 1, 8, 15, 29, Aug 12, 26, Sep 9